From Medscape Gastroenterology

Coverage from the

International Liver Congress (ILC) 2022

June 22 - 26, 2022; Virtual/London, England

June 22 - 26, 2022 Virtual/London, England

ILC 2022 In Two Analyses, MAESTRO-NAFLD-1 Trial Shows Safety of Resmetirom In main results from the phase 3 trial, as well as those from an open-label extension, the investigational drug also proved its ability to positively influence several noninvasive efficacy outcomes.
Medscape Medical News, June 30, 2022
ILC 2022 Low-Carb, High-Fat Diet Improves A1c, Reduces Liver Fat: Study A low-carb, high-fat diet reduced NAFLD activity score and HbA1c, and resulted in weight loss, according to a 6-month study of participants with NAFLD and type 2 diabetes.
Medscape Medical News, June 27, 2022

Conference News

ILC 2022 Statins in NAFLD: Taking a Closer Look at Benefits
Medscape Medical News, July 6, 2022
ILC 2022 Bulevirtide Reduces Hepatitis D Viral Load
Medscape Medical News, July 6, 2022
ILC 2022 Bulevirtide Beneficial in Hepatitis D: Phase 3 Data
Medscape Medical News, July 6, 2022
ILC 2022 HBV Cure Going Back to the Drawing Board, Researchers Say
Medscape Medical News, July 5, 2022
ILC 2022 Pemvidutide Promising for Fatty Liver Disease
Medscape Medical News, June 30, 2022

ILC 2022 In Two Analyses, MAESTRO-NAFLD-1 Trial Shows Safety of Resmetirom
Medscape Medical News, June 30, 2022
ILC 2022 Novel Liver-Targeting Drug Offers Hope for AAT Deficiency
Medscape Medical News, June 28, 2022
ILC 2022 Fatty Liver Disease Drives Rise in Liver Cancer Deaths
Medscape Medical News, June 27, 2022
ILC 2022 Low-Carb, High-Fat Diet Improves A1c, Reduces Liver Fat: Study
Medscape Medical News, June 27, 2022
ILC 2022 Acute Hepatitis Cases in Children Show Declining Trend
Medscape Medical News, June 24, 2022

Medscape Gastroenterology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News from ILC 2021

Hepatitis C Antivirals May Fight SARS-CoV-2 Sofosbuvir/ledipasvir and nitazoxanide both appeared to clear SARS-CoV-2 infections in a preliminary trial.
Medscape Medical News, Jun 28, 2021
COVID-19 Vaccinations May Be Weakened by Liver Disease A researcher recommends testing people with liver disease for antibodies after vaccinating them with the Pfizer vaccine against COVID-19, with the possibility of a third dose in mind.
Medscape Medical News, Jun 23, 2021
Calories May Outweigh Nutrients in Diets for Fatty Liver Calories may matter more than fat or carbohydrates in dieting to treat non-alcoholic fatty liver disease.
Medscape Medical News, Jun 25, 2021

Previous Coverage

Related Resources